Friday, November 22, 2024
HomeTagsDF7001

DF7001

Gilead and Dragonfly Announce Strategic Research Collaboration to Develop Natural Killer Cell Engagers in Oncology and Inflammation

Gilead Sciences, Inc. and Dragonfly Therapeutics announced a collaboration designed to advance a number of Dragonfly's novel natural killer (NK) cell engager-based immunotherapies for...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics